SCHEMBL14172009

SCHEMBL14172009

CNC1CCCC(C)(C)N(Cc2ncncn2)C1=O

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 1/20 0.36
▸ CYP11B2 P19099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14172008 0.83 ACE (0.36) ACE
SCHEMBL14172000 0.82 ACE (0.35) ACE
SCHEMBL14172007 0.82 ACE (0.35) ACE
SCHEMBL14172005 0.80 ACE (0.41) ACE
SCHEMBL14172012 0.80 OPRM1 (0.39) ACE
SCHEMBL14172002 0.78 ACE (0.35) ACECYP11B2
SCHEMBL14171993 0.77 XIAP (0.39) ACE
SCHEMBL14172004 0.77 XIAP (0.41) ACE
SCHEMBL14171988 0.77 ACE (0.37) ACE
SCHEMBL14171989 0.77 ALOX15 (0.40) ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7390801-B2 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds ATHENA NEUROSCIENCES, INC. (US) 2008-06-24 — — US disclosed
Send feedback